Skip to main content
Caplight Logo









KCell Biosciences

KCell Biosciences

Private
BusanHealthcare & Life Scienceshttps://k-cell.com/

Last Round

Corporate Funding

Mar 7, 2025

Total Funding Raised

$8.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

KCell Biosciences is a biotechnology company that manufactures serum-free and chemically defined cell culture media for biopharmaceutical and cultivated food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

cell culture mediaCDMOcontract development and manufacturing organizationserum-free mediachemically defined mediacell line developmentbioprocess developmentcultivated meatlab-grown meatbiopharma manufacturingtransient transfectionmedia optimizationbasal mediabiotech supply chaincellular agriculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KCell Biosciences Comparables

Compare KCell Biosciences with similar companies based on industry and business-model similarity.

KCell Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Welgene Inc.
83%
Defined Bioscience
81%
Thousand Oaks Biopharmaceuticals
75%

KCell Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMar 7, 2025
Series AJul 12, 2022

Key People

Founding team and executive leadership

Victor Kang

Chief Executive Officer

Executive Team

Kwon hee Lee

경영관리(CFO)

Executive Team

KCell Biosciences Investors

Notable investors and investment history

KCell Biosciences investors
InvestorRounds
CKD Venture CapitalSeries A
DAYLI PartnersSeries A
Sema InvestmentSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 81% MoM.

  • Dec 9, 2025

    Monthly visitors increased 32% MoM.

KCell Biosciences Filings

Explore SEC and related filing metadata, where available.

KCell Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KCell Biosciences's valuation, stock price, and market status.

Is KCell Biosciences a public or private company?

KCell Biosciences is a private company.

What is the current stock price of KCell Biosciences?

KCell Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is KCell Biosciences worth (valuation)?

Valuation information for KCell Biosciences is not publicly available.

Can I buy KCell Biosciences stock?

KCell Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KCell Biosciences's last funding round?

KCell Biosciences's most recent funding round was Corporate Funding on March 7, 2025.

Who are the main investors in KCell Biosciences?

Key investors in KCell Biosciences include CKD Venture Capital, DAYLI Partners, Sema Investment.

Will KCell Biosciences IPO soon?

No public IPO plans have been announced for KCell Biosciences.

How can I track KCell Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KCell Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBusan
Employee Range6
Year Founded2021
Last FundingMar 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?